日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Association of Angiotensin Receptor-Neprilysin Inhibitors Use and Better Cardiorenal Outcomes in Patients With Heart Failure and Acute Kidney Disease

血管紧张素受体-脑啡肽酶抑制剂的使用与心力衰竭合并急性肾病患者更好的心肾预后相关

Chen, Jui-Yi; Pan, Heng-Chih; Wu, Vin-Cent

Assessing the utility of fractional excretion of urea in distinguishing intrinsic and prerenal acute kidney injury in hospitalised patients: a systematic review and meta-analysis

评估尿素排泄分数在区分住院患者肾内性和肾前性急性肾损伤中的应用价值:系统评价和荟萃分析

Pan, Heng-Chih; Jiang, Zheng-Hong; Chen, Hsing-Yu; Liu, Jung-Hua; Chen, Yu-Wei; Peng, Kang-Yung; Wu, Vin-Cent; Hsiao, Ching-Chung

Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease

机器学习辅助发现揭示了肠道菌群与糖尿病肾病宿主代谢紊乱之间的新型相互作用

Wu, I-Wen; Liao, Yu-Chieh; Tsai, Tsung-Hsien; Lin, Chieh-Hua; Shen, Zhao-Qing; Chan, Yun-Hsuan; Tu, Chih-Wei; Chou, Yi-Ju; Lo, Chi-Jen; Yeh, Chi-Hsiao; Chen, Chun-Yu; Pan, Heng-Chih; Hsu, Heng-Jung; Lee, Chin-Chan; Cheng, Mei-Ling; Sheu, Wayne Huey-Herng; Lai, Chi-Chun; Sytwu, Huey-Kang; Tsai, Ting-Fen

Immune checkpoint inhibitors-associated acute kidney injury: a systematic review and meta-analysis of incidence, kidney recovery, and recurrent risk

免疫检查点抑制剂相关急性肾损伤:发生率、肾脏恢复和复发风险的系统评价和荟萃分析

Ho, Cheng-Wei; Kang, Nai-Wen; Yeh, Tzu-Hsuan; Chuang, Min-Hsiang; Tsai, Wen-Wen; Wang, Hsien-Yi; Wu, Vin-Cent; Pan, Heng-Chih; Chen, Jui-Yi

Dipeptidyl peptidase 4 inhibitors reduce the risk of adverse outcomes after acute kidney injury in diabetic patients

二肽基肽酶4抑制剂可降低糖尿病患者急性肾损伤后不良后果的风险

Liao, Hung-Wei; Cheng, Chung-Yi; Chen, Hsing-Yu; Chen, Jui-Yi; Pan, Heng-Chih; Huang, Tao-Min; Wu, Vin-Cent

Trajectories of urea‑to‑creatinine ratio and risk of clinical outcomes in survivors of acute kidney disease: a population-based study

急性肾病幸存者尿素/肌酐比值变化轨迹与临床结局风险:一项基于人群的研究

Pan, Heng-Chih; Chen, Jui-Yi; Teng, Nai-Chi; Yeh, Fang-Yu; See, Chun Yin; Sun, Chiao-Yin; Wu, Vin-Cent; Chen, Likwang

Cu-Doping Induced Structural Transformation and Magnetocaloric Enhancement in CoCr(2)O(4) Nanoparticles

Cu掺杂诱导CoCr(2)O(4)纳米粒子的结构转变和磁热增强

Ho, Ming-Kang; Yu, Yun-Tai; Chiu, Hsin-Hao; Manjunatha, K; Yu, Shih-Lung; Lyu, Bing-Li; Hsu, Tsu-En; Kuo, Heng-Chih; Yu, Shuan-Wei; Tu, Wen-Chi; Chang, Chiung-Yu; Cheng, Chia-Liang; Nagabhushana, H; Lin, Tsung-Te; Hsu, Yi-Ru; Chen, Meng-Chu; Huang, Yue-Lin; Wu, Sheng Yun

A Multi-Stage Framework for Kawasaki Disease Prediction Using Clustering-Based Undersampling and Synthetic Data Augmentation: Cross-Institutional Validation with Dual-Center Clinical Data in Taiwan

基于聚类欠采样和合成数据增强的川崎病预测多阶段框架:台湾双中心临床数据的跨机构验证

Huang, Heng-Chih; Hung, Chuan-Sheng; Lin, Chun-Hung Richard; Shie, Yi-Zhen; Yu, Cheng-Han; Huang, Ting-Hsin

Comparison of Acute Kidney Disease Staging by Estimated Glomerular Filtration Rate and by Serum Creatinine Ratio in Patients With Dialysis-requiring Acute Kidney Injury: A National Cohort Study From Taiwan

台湾一项全国性队列研究比较了透析依赖性急性肾损伤患者根据估算肾小球滤过率和血清肌酐比值进行急性肾脏疾病分期的效果。

Pan, Szu-Yu; Teng, Nai-Chi; Huang, Thomas Tao-Min; Chang, Chih-Hsiang; Pan, Heng-Chih; Lin, Ming-Yen; Wang, Shi-Heng; Hsu, Chih-Cheng; Lin, Shuei-Liong; Wu, Vin-Cent; Chen, Likwang

Evaluation of generative AI assistance in clinical nephrology: Assessing GPT-4, GPT-4o, Gemini 1.0 Ultra, and PaLM 2 in patient interaction and renal biopsy interpretation

评估生成式人工智能在临床肾脏病学中的辅助应用:评估 GPT-4、GPT-4o、Gemini 1.0 Ultra 和 PaLM 2 在患者互动和肾活检结果解读方面的应用

Lin, Shih-Yi; Jiang, Chang-Cheng; Law, Kin-Man; Yeh, Pei-Chun; Tsai, Min-Kuang; Chou, Chu-Lin; Wang, I-Kuan; Ting, I-Wen; Chen, Yu-Wei; Chou, Che-Yi; Hsieh, Ming-Han; Pan, Heng-Chih; Hsieh, Sung-Lin; Chiu, Chien-Hua; Lee, Pei-Wen; Hong, Yu-Cyuan; Hsu, Ying-Yu; Kuo, Huey-Liang; Ju, Shu-Woei; Kao, Chia-Hung